Ionis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report
Ionis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report
Abstract
Summary
Ionis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Ionis Pharmaceuticals, Inc. (Ionis or ‘the company’) is involved in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The company develops drugs for patients with significant unmet medical needs. Its products pipeline contains two near-term potentially transformative medicines for two different severe and rare diseases. The company develops drugs for the treatment of a wide range of diseases including, cardiovascular disease, clotting disorders, Alzheimer’s, and Parkinson’s disease, and also some rare diseases, such as acromegaly, amyotrophic lateral sclerosis, beta-thalassemia, and Huntington’s disease. Ionis uses antisense technology in the development of its drugs. It primarily operates in the US. The company is headquartered in Carlsbad, California, the US
Scope
- Detailed information on Ionis Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Ionis Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Ionis Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Intelligence on Ionis Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Ionis Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of Ionis Pharmaceuticals, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Ionis Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Ionis Pharmaceuticals, Inc.'s business structure, strategy and prospects.
Content
Table of Contents
Company Snapshot
Ionis Pharmaceuticals, Inc.: Company Overview
Ionis Pharmaceuticals, Inc.: Overview and Key Facts
Ionis Pharmaceuticals, Inc.: Overview
Ionis Pharmaceuticals, Inc.: Key Facts
Ionis Pharmaceuticals, Inc.: Key Employees
Ionis Pharmaceuticals, Inc.: Key Employee Biographies
Ionis Pharmaceuticals, Inc.: Major Products and Services
Ionis Pharmaceuticals, Inc.: Company History
Ionis Pharmaceuticals, Inc.: Management Statement
Ionis Pharmaceuticals, Inc.: Locations and Subsidiaries
Ionis Pharmaceuticals, Inc.: Key Competitors
Ionis Pharmaceuticals, Inc.: Company Analysis
Ionis Pharmaceuticals, Inc.: Business Description
Ionis Pharmaceuticals, Inc.: SWOT Analysis
Ionis Pharmaceuticals, Inc.: SWOT Overview
Ionis Pharmaceuticals, Inc.: Strengths
Ionis Pharmaceuticals, Inc.: Weaknesses
Ionis Pharmaceuticals, Inc.: Opportunities
Ionis Pharmaceuticals, Inc.: Threats
Ionis Pharmaceuticals, Inc.: Corporate Financial Deals Activity
Ionis Pharmaceuticals, Inc.: Financial Deals Overview
Ionis Pharmaceuticals, Inc.: Targets and Partners
Ionis Pharmaceuticals, Inc.: Top Deals 2019 - 2023YTD*
Ionis Pharmaceuticals, Inc.: Advisors
Ionis Pharmaceuticals, Inc.: Top Legal Advisors
Ionis Pharmaceuticals, Inc.: Top Financial Advisors
Ionis Pharmaceuticals, Inc.: Mergers and Acquisitions
Ionis Pharmaceuticals, Inc.: Corporate Venturing
Ionis Pharmaceuticals, Inc.: Capital Raising
Ionis Pharmaceuticals, Inc.: Partnership
Ionis Pharmaceuticals, Inc.: Divestments
Ionis Pharmaceuticals, Inc.: Recent Developments
Ionis Pharmaceuticals, Inc.: News and Events Summary
Ionis Pharmaceuticals, Inc.: Business Expansion
Ionis Pharmaceuticals, Inc.: Financial Deals
Ionis Pharmaceuticals, Inc.: Financial Performance
Ionis Pharmaceuticals, Inc.: Market Developments
Ionis Pharmaceuticals, Inc.: Regulatory and Legal Events
Ionis Pharmaceuticals, Inc.: Research & Development
Appendix
Contact Us
Methodology
About MarketLine
List of Tables
Table 1: Ionis Pharmaceuticals, Inc.: Key Facts
Table 2: Ionis Pharmaceuticals, Inc.: Key Employees
Table 3: Ionis Pharmaceuticals, Inc.: Company History
Table 4: Ionis Pharmaceuticals, Inc.: Locations and Subsidiaries
Table 5: Ionis Pharmaceuticals, Inc.: Key Competitors
Table 6: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Table 8: Ionis Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Ionis Pharmaceuticals, Inc.: Targets and Partners
Table 10: Ionis Pharmaceuticals, Inc.: Top Deals 2019 - 2023YTD*
Table 11: Ionis Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Ionis Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Ionis Pharmaceuticals, Inc.: M&A Volume and Value Trend (2019 - YTD*2023)
Table 14: Ionis Pharmaceuticals, Inc.: M&A Activity by Geography (2019 - YTD*2023)
Table 15: Ionis Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Table 16: Ionis Pharmaceuticals, Inc.: Corporate Venturing by Geography (2019 - YTD*2023)
Table 17: Ionis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Table 18: Ionis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2019 - YTD*2023)
Table 19: Ionis Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2019 - YTD*2023)
Table 20: Ionis Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2019 - YTD*2023)
Table 21: Ionis Pharmaceuticals, Inc.: Divestments Volume and Value Trend (2019 - YTD*2023)
Table 22: Ionis Pharmaceuticals, Inc.: News and Events Summary
Table 23: Ionis Pharmaceuticals, Inc.: Business Expansion
Table 24: Ionis Pharmaceuticals, Inc.: Financial Deals
Table 25: Ionis Pharmaceuticals, Inc.: Financial Performance
Table 26: Ionis Pharmaceuticals, Inc.: Market Developments
Table 27: Ionis Pharmaceuticals, Inc.: Regulatory and Legal Events
Table 28: Ionis Pharmaceuticals, Inc.: Research & Development
List of Figures
Figure 1: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Figure 3: Ionis Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: Ionis Pharmaceuticals, Inc.: M&A Volume and Value Trend (2019 - YTD*2023)
Figure 5: Ionis Pharmaceuticals, Inc.: M&A Activity by Geography (2019 - YTD*2023)
Figure 6: Ionis Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Figure 7: Ionis Pharmaceuticals, Inc.: Corporate Venturing by Geography (2019 - YTD*2023)
Figure 8: Ionis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Figure 9: Ionis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2019 - YTD*2023)
Figure 10: Ionis Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2019 - YTD*2023)
Figure 11: Ionis Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2019 - YTD*2023)
Figure 12: Ionis Pharmaceuticals, Inc.: Divestments Volume and Value Trend (2019 - YTD*2023)
Summary
Ionis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Ionis Pharmaceuticals, Inc. (Ionis or ‘the company’) is involved in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The company develops drugs for patients with significant unmet medical needs. Its products pipeline contains two near-term potentially transformative medicines for two different severe and rare diseases. The company develops drugs for the treatment of a wide range of diseases including, cardiovascular disease, clotting disorders, Alzheimer’s, and Parkinson’s disease, and also some rare diseases, such as acromegaly, amyotrophic lateral sclerosis, beta-thalassemia, and Huntington’s disease. Ionis uses antisense technology in the development of its drugs. It primarily operates in the US. The company is headquartered in Carlsbad, California, the US
Scope
- Detailed information on Ionis Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Ionis Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Ionis Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Intelligence on Ionis Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Ionis Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of Ionis Pharmaceuticals, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Ionis Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Ionis Pharmaceuticals, Inc.'s business structure, strategy and prospects.
Table of Contents
Company Snapshot
Ionis Pharmaceuticals, Inc.: Company Overview
Ionis Pharmaceuticals, Inc.: Overview and Key Facts
Ionis Pharmaceuticals, Inc.: Overview
Ionis Pharmaceuticals, Inc.: Key Facts
Ionis Pharmaceuticals, Inc.: Key Employees
Ionis Pharmaceuticals, Inc.: Key Employee Biographies
Ionis Pharmaceuticals, Inc.: Major Products and Services
Ionis Pharmaceuticals, Inc.: Company History
Ionis Pharmaceuticals, Inc.: Management Statement
Ionis Pharmaceuticals, Inc.: Locations and Subsidiaries
Ionis Pharmaceuticals, Inc.: Key Competitors
Ionis Pharmaceuticals, Inc.: Company Analysis
Ionis Pharmaceuticals, Inc.: Business Description
Ionis Pharmaceuticals, Inc.: SWOT Analysis
Ionis Pharmaceuticals, Inc.: SWOT Overview
Ionis Pharmaceuticals, Inc.: Strengths
Ionis Pharmaceuticals, Inc.: Weaknesses
Ionis Pharmaceuticals, Inc.: Opportunities
Ionis Pharmaceuticals, Inc.: Threats
Ionis Pharmaceuticals, Inc.: Corporate Financial Deals Activity
Ionis Pharmaceuticals, Inc.: Financial Deals Overview
Ionis Pharmaceuticals, Inc.: Targets and Partners
Ionis Pharmaceuticals, Inc.: Top Deals 2019 - 2023YTD*
Ionis Pharmaceuticals, Inc.: Advisors
Ionis Pharmaceuticals, Inc.: Top Legal Advisors
Ionis Pharmaceuticals, Inc.: Top Financial Advisors
Ionis Pharmaceuticals, Inc.: Mergers and Acquisitions
Ionis Pharmaceuticals, Inc.: Corporate Venturing
Ionis Pharmaceuticals, Inc.: Capital Raising
Ionis Pharmaceuticals, Inc.: Partnership
Ionis Pharmaceuticals, Inc.: Divestments
Ionis Pharmaceuticals, Inc.: Recent Developments
Ionis Pharmaceuticals, Inc.: News and Events Summary
Ionis Pharmaceuticals, Inc.: Business Expansion
Ionis Pharmaceuticals, Inc.: Financial Deals
Ionis Pharmaceuticals, Inc.: Financial Performance
Ionis Pharmaceuticals, Inc.: Market Developments
Ionis Pharmaceuticals, Inc.: Regulatory and Legal Events
Ionis Pharmaceuticals, Inc.: Research & Development
Appendix
Contact Us
Methodology
About MarketLine
List of Tables
Table 1: Ionis Pharmaceuticals, Inc.: Key Facts
Table 2: Ionis Pharmaceuticals, Inc.: Key Employees
Table 3: Ionis Pharmaceuticals, Inc.: Company History
Table 4: Ionis Pharmaceuticals, Inc.: Locations and Subsidiaries
Table 5: Ionis Pharmaceuticals, Inc.: Key Competitors
Table 6: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Table 8: Ionis Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Ionis Pharmaceuticals, Inc.: Targets and Partners
Table 10: Ionis Pharmaceuticals, Inc.: Top Deals 2019 - 2023YTD*
Table 11: Ionis Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Ionis Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Ionis Pharmaceuticals, Inc.: M&A Volume and Value Trend (2019 - YTD*2023)
Table 14: Ionis Pharmaceuticals, Inc.: M&A Activity by Geography (2019 - YTD*2023)
Table 15: Ionis Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Table 16: Ionis Pharmaceuticals, Inc.: Corporate Venturing by Geography (2019 - YTD*2023)
Table 17: Ionis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Table 18: Ionis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2019 - YTD*2023)
Table 19: Ionis Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2019 - YTD*2023)
Table 20: Ionis Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2019 - YTD*2023)
Table 21: Ionis Pharmaceuticals, Inc.: Divestments Volume and Value Trend (2019 - YTD*2023)
Table 22: Ionis Pharmaceuticals, Inc.: News and Events Summary
Table 23: Ionis Pharmaceuticals, Inc.: Business Expansion
Table 24: Ionis Pharmaceuticals, Inc.: Financial Deals
Table 25: Ionis Pharmaceuticals, Inc.: Financial Performance
Table 26: Ionis Pharmaceuticals, Inc.: Market Developments
Table 27: Ionis Pharmaceuticals, Inc.: Regulatory and Legal Events
Table 28: Ionis Pharmaceuticals, Inc.: Research & Development
List of Figures
Figure 1: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Figure 3: Ionis Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: Ionis Pharmaceuticals, Inc.: M&A Volume and Value Trend (2019 - YTD*2023)
Figure 5: Ionis Pharmaceuticals, Inc.: M&A Activity by Geography (2019 - YTD*2023)
Figure 6: Ionis Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Figure 7: Ionis Pharmaceuticals, Inc.: Corporate Venturing by Geography (2019 - YTD*2023)
Figure 8: Ionis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Figure 9: Ionis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2019 - YTD*2023)
Figure 10: Ionis Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2019 - YTD*2023)
Figure 11: Ionis Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2019 - YTD*2023)
Figure 12: Ionis Pharmaceuticals, Inc.: Divestments Volume and Value Trend (2019 - YTD*2023)
Related Report
